2 results match your criteria: "University Hospital General de Alicante[Affiliation]"
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.
Infection
June 2021
Infectious Disease Department, University Hospital Ramon Y Cajal, Ctra. Colmenar Viejo, Km 9,1. Zip code 28034, Madrid, Spain.
The high cost of fidaxomicin has restricted its use despite the benefit of a lower Clostridioides difficile infection (CDI) recurrence rate at 4 weeks of follow-up. This short follow-up represents the main limitation of pivotal clinical trials of fidaxomicin, and some recent studies question its benefits over vancomycin. Moreover, the main risk factors of recurrence after treatment with fidaxomicin remain unknown.
View Article and Find Full Text PDFLooking for a needle in a haystack.
Eur J Rheumatol
January 2019
Department of Rheumatology, University Hospital General de Alicante, Alicante, Spain.